Triaza-18-Crown-6 Macrocycle Scaffold: Chelator Platform for Theranostic Application D Fiaccabrino, C Orvig, P Schaffer Nuclear Medicine and Biology 126, 108409, 2023 | | 2023 |
Rearmed Bifunctional Chelating Ligand for 225Ac/155Tb Precision-Guided Theranostic Radiopharmaceuticals─H4noneunpaX L Wharton, H Yang, MG Jaraquemada-Peláez, H Merkens, G Engudar, ... Journal of Medicinal Chemistry 66 (19), 13705-13730, 2023 | 4 | 2023 |
Production and radiochemistry of antimony-120m: Efforts toward Auger electron therapy with 119Sb TI Kostelnik, AP Olson, A Grundmane, PA Ellison, J Mynerich, S Chen, ... Nuclear Medicine and Biology 122, 108352, 2023 | 2 | 2023 |
Toward 68Ga and 64Cu Positron Emission Tomography Probes: Is H2dedpa-N,N′-pram the Missing Link for dedpa Conjugation? C Pena-Bonhome, D Fiaccabrino, T Rama, D Fernández-Pavón, ... Inorganic Chemistry 62 (50), 20593-20607, 2023 | 3 | 2023 |
H3TPAN-Triazole-Bn-NH2: Tripicolinate Clicked-Bifunctional Chelate for [225Ac]/[111In] Theranostics L Wharton, C Zhang, J Zeisler, C Rodriguez-Rodriguez, M Osooly, ... Bioconjugate Chemistry 33 (12), 2381-2397, 2022 | 4 | 2022 |
Triaza-18-crown-6 macrocyclic chelators for the [203: 212Pb] Pb2+ theranostic pair D Fiaccabrino, B McNeil, C Orvig, P Schaffer Nuclear Medicine and Biology 114, S66, 2022 | | 2022 |
Towards bifunctional chelators for thallium-201 for use in nuclear medicine A Rigby, G Firth, C Rivas, T Pham, J Kim, A Phanopoulos, L Wharton, ... Nuclear Medicine and Biology 114, S10, 2022 | | 2022 |
Trastuzumab-conjugated oxine-based ligand for [89Zr] Zr4+ immunoPET L Southcott, L Wharton, J Rousseau, H Merkens, H Yang, F Bénard, ... Journal of Inorganic Biochemistry 235, 111936, 2022 | 4 | 2022 |
H4picoopa─Robust Chelate for 225Ac/111In Theranostics L Wharton, MG Jaraquemada-Pelaez, C Zhang, J Zeisler, ... Bioconjugate Chemistry 33 (10), 1900-1921, 2022 | 8 | 2022 |
Toward Bifunctional Chelators for Thallium-201 for Use in Nuclear Medicine A Rigby, G Firth, C Rivas, T Pham, J Kim, A Phanopoulos, L Wharton, ... Bioconjugate chemistry 33 (7), 1422-1436, 2022 | 4 | 2022 |
Glypican-3–Targeted 227Th α-Therapy Reduces Tumor Burden in an Orthotopic Xenograft Murine Model of Hepatocellular Carcinoma KP Labadie, DK Hamlin, A Kenoyer, SK Daniel, AF Utria, AD Ludwig, ... Journal of Nuclear Medicine 63 (7), 1033-1038, 2022 | 8 | 2022 |
H (2) ampa-Versatile Chelator for [Pb-203] Pb2+,[Bi-213] Bi3+, and [Ac-225] Ac3+ A Ingham, L Wharton, T El Sayed, L Southcott, BL McNeil, MB Ezhova, ... INORGANIC CHEMISTRY 61 (24), 9119-9137, 2022 | | 2022 |
H2ampa─Versatile Chelator for [203Pb]Pb2+, [213Bi]Bi3+, and [225Ac]Ac3+ A Ingham, L Wharton, T El Sayed, L Southcott, BL McNeil, MB Ezhova, ... Inorganic Chemistry 61 (24), 9119-9137, 2022 | 9 | 2022 |
Bis (amido) bis (oxinate) diamine Ligands for theranostic radiometals L Southcott, JN Whetter, L Wharton, BO Patrick, K Zarschler, M Kubeil, ... Journal of Inorganic Biochemistry 231, 111789, 2022 | 1 | 2022 |
Chelators and methods of making and using same LLL LI, C Orvig, F Benard, K Lin, JM Rousseau, I Samudio US Patent App. 17/441,125, 2022 | | 2022 |
Production of emerging theranostic radionuclides at TRIUMF V Radchenko, E Kurakina, L Wharton, B McNeil, G Engudar, H Yang, ... Nuclear Medicine and Biology 108, S172, 2022 | | 2022 |
TRIHOPO: 1, 2-HOPO-based macrocyclic chelator for 225Ac, 227Th, and 89Zr D Fiaccabrino, L Wharton, C Orvig, P Schaffer Nuclear Medicine and Biology 108, S55, 2022 | | 2022 |
[213Bi]Bi3+/[111In]In3+-neunpa-cycMSH: Theranostic Radiopharmaceutical Targeting Melanoma─Structural, Radiochemical, and Biological Evaluation L Wharton, C Zhang, H Yang, J Zeisler, V Radchenko, ... Bioconjugate Chemistry 33 (3), 505-522, 2022 | 5 | 2022 |
Improved separation scheme for 44Sc produced by irradiation of natCa targets with 12.8 MeV protons ES Kurakina, L Wharton, C Hoehr, C Orvig, EP Magomedbekov, ... Nuclear Medicine and Biology 104, 22-27, 2022 | 8 | 2022 |
Harnessing α-emitting radionuclides for therapy: radiolabeling method review H Yang, JJ Wilson, C Orvig, Y Li, DS Wilbur, CF Ramogida, V Radchenko, ... Journal of Nuclear Medicine 63 (1), 5-13, 2022 | 38 | 2022 |